Commentary on 'The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer'

Crook Juanita

首页> 外文期刊>Brachytherapy >Commentary on 'The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer'

【24h】

Commentary on 'The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer'

机译：关于“高剂量率近距离放射治疗对中危前列腺癌的影响，持续性前列腺癌细胞对前列腺活检的临床意义”评论

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Brachytherapy》 |2015年第3期|共1页
作者
Crook Juanita;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类放射医学;
关键词

相似文献

外文文献
中文文献
专利

1. Commentary on "The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer" [J] . Crook Juanita Brachytherapy . 2015,第3期

机译：关于“高剂量率近距离放射治疗对中危前列腺癌的影响，持续性前列腺癌细胞对前列腺活检的临床意义”评论
2. Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients [J] . MarinaO., GustafsonG.S., KestinL.L., Brachytherapy . 2014,第1期

机译：在现代的中危前列腺癌患者队列中，以剂量为导向，以图像为导向的放射疗法与以剂量为导向，高剂量率近距离放射疗法的比较
3. Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer? [J] . Linson PW, Lee AK, Doytchinova T, Urology . 2002,第5期

机译：前列腺癌涉及的核心长度百分比：在预测中度前列腺癌男性患者术后前列腺特异性抗原结果时，它是否增加了前列腺活检阳性的百分比？
4. Simulated prostate biopsy: prostate cancer distribution and clinical correlation [C] . John J. Bauer, Walter Reed Army Medical Ctr., Uniformed Services Univ. of the Health Sciences, Medical Imaging 2000: Image Display and Visualization . 2000

机译：模拟前列腺活检：前列腺癌分布和临床相关性
5. A comparative study of quality of life in patients with low-and intermediate-risk prostate cancer treated at a single institution: Stereotactic radiotherapy vs. high dose-rate brachytherapy monotherapy vs. high dose-rate brachytherapy boost [D] . Helou, Joelle. 2017

机译：单一机构治疗的中低危前列腺癌患者生活质量的比较研究：立体定向放疗与高剂量率近距离放射疗法单药疗法与高剂量率近距离放射疗法增强
6. Low-/high-dose-rate brachytherapy boost in patients with intermediate-risk prostate cancer treated with radiotherapy: long-term results from a single institution team experience [O] . Silvia Rodríguez Villalba, Paula Monasor Denia, Maria Jose Pérez-Calatayud, 2021

机译：用放射治疗的中间风险前列腺癌患者的低/高剂量速率近距离放射治疗：由单一机构团队经验的长期结果
7. MP14-20 PROSTATE IMAGING REPORTING AND DATA SYSTEM SCORE BEFORE PROSTATE BIOPSY CAN PREDICT BIOCHEMICAL FAILURE IN PROSTATE CANCER PATIENTS TREATED WITH HIGH-DOSE-RATE BRACHYTHERAPY [O] . Keisuke Hata, Junpei Iizuka, Yasunobu Hashimoto, 2016

机译：PM14-20前列腺成像报告和数据系统得分前列前列腺活检可以预测高剂量速率近距离放射治疗治疗前列腺癌患者的生物化学衰竭

Commentary on 'The clinical significance of persistent prostate cancer cells on prostate biopsy after high-dose-rate brachytherapy boost for intermediate-risk prostate cancer'

著录项

相似文献

相关主题

期刊订阅